Showing results (61-70 of 756) with videos related to

Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|October 31, 2025
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trialGideon M Hirschfield, Christopher L Bowlus, David E J Jones, et al.
The Lancet. Gastroenterology & Hepatology|September 13, 2025
Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort studyNikolaj Torp, Katrine Tholstrup Bech, Helle Lindholm Schnefeld, et al.
The Lancet. Gastroenterology & Hepatology|August 9, 2017
Human liver flukesDavid Harrington, Poppy H L Lamberton, Alastair McGregor
The Lancet. Gastroenterology & Hepatology|August 14, 2017
Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trialsEric Lawitz, Maria Buti, John M Vierling, et al.
The Lancet. Gastroenterology & Hepatology|August 14, 2017
Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trialsEdward J Gane, Stephen Pianko, Stuart K Roberts, et al.
The Lancet. Gastroenterology & Hepatology|August 23, 2017
Neurostimulation for abdominal pain-related functional gastrointestinal disorders in adolescents: a randomised, double-blind, sham-controlled trialKatja Kovacic, Keri Hainsworth, Manu Sood, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2017
Cirrhosis with ascites in the last year of life: a nationwide analysis of factors shaping costs, health-care use, and place of death in EnglandBenjamin Hudson, Jeff Round, Brendan Georgeson, et al.
The Lancet. Gastroenterology & Hepatology|December 16, 2017
Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trialSandra Andorf, Natasha Purington, Whitney M Block, et al.
The Lancet. Gastroenterology & Hepatology|October 4, 2017
Effect of diagnosis, surveillance, and treatment of Barrett's oesophagus on health-related quality of lifeJames Britton, Richard Keld, Neeraj Prasad, et al.
The Lancet. Gastroenterology & Hepatology|September 24, 2017
Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort studyJeffrey S Hyams, Sonia Davis, David R Mack, et al.
Pageof 76